AzTrials
AzTrials

DepressionSIBSNCT03766360

Bariatric Surgery Study

A study testing Functional Analytical Psychotherapy (FAP) in people with Depression and Quality of Life, run by University of Washington at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The current study proposes an open clinical trial to investigate the effectiveness of a social functioning intervention on bariatric surgery outcomes and depression. The treatment will be administered in a group format over 10 weekly/biweekly sessions and will take place at the University of Washington Weight Loss… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Functional Analytical Psychotherapy (FAP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Jan 2019to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Older than 18
  • Speak English as a primary language
  • Had Bariatric Surgery in the past 6-24 months (bypasses (Roux-en-Y) or sleeves)
  • Yes to one or both of the first two PHQ-9 Questions
  • Not pregnant
  • Not traveling anywhere in the next 6 months
  • No surgeries scheduled in the next 12 months

Who cannot join

  • No exclusion criteria are utilized in the present study.

Trial locations and contacts

1 site in 1 country.

Jonathan Kanter, PhD contact

206-685-7462

jonkan@uw.edu

Elliot Wallace contact

206-685-7462

elliotcw@uw.edu

United States1 site
  • Weight Loss Management Center at UWMC-Roosevelt

    Seattle, Washington, 98105

    Ruth Foster-Koth, MA, 206-598-1752, rfosterk@uw.edu

Other trials in United States

About this study

Official title: A Social Functioning Intervention to Target Depression Post Bariatric Surgery

The current study proposes an open clinical trial to investigate the effectiveness of a social functioning intervention on bariatric surgery outcomes and depression. The treatment will be administered in a group format over 10 weekly/biweekly sessions and will take place at the University of Washington Weight Loss Management Clinic (WLMC) at the Roosevelt Clinic location. Effects of the intervention will be measured with self-report questionnaires and by self-report of behaviors outside of assessment sessions (via questionnaires and self-report of adherence to treatment). Data collection will occur at specific time points including before treatment, after treatment, and two months after treatment.

Read the detailed description

As of 2009, 344,000 bariatric procedures were performed annually . Although some studies report depressive symptoms decrease in the 6 months after bariatric surgery, there is growing body of literature suggesting there exists a subgroup of patients whose depressive symptoms worsen after surgery and the likelihood of developing depressive symptoms increases longitudinally. Depression can be an indicator of an increased risk of self-harm and additional studies have found that the risk of suicide may increase post bariatric surgery compared to obese individuals who have not undergone surgery.

Research supports that psychosocial factors contribute to successful postoperative outcomes. Functional Analytic Psychotherapy shows potential to impact social variables that may be relevant to bariatric surgery outcomes including depression. In this context, FAP aims to improve interpersonal relationships through experientially teaching skills intended to increase social connection. FAP also seeks to increase awareness, which includes the ability to view interpersonal interactions from multiple perspectives, allowing new interpersonal skills to emerge.

The present study seeks to evaluate the use of a FAP group to enhance interpersonal relating with a sample of post-bariatric surgery patients. Measures will be collected on quality of life and variables involved in interpersonal connectedness.

Being tested
Functional Analytical Psychotherapy (FAP)
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional Analytical Psychotherapy (FAP)Behavioural

    The intervention itself is based on the procedures of Functional Analytic Psychotherapy, a behavioral intervention focusing on improving social functioning.

Study groups in NCT03766360
Study groupRoleWhat they receive
FAP Intervention GroupExperimentalAll of the clients in the FAP intervention group will begin treatment at the same time and complete 3 assessments.
Receives: Behavioral: Functional Analytical Psychotherapy (FAP)
Control GroupNo interventionThe clients in the control group will take their assessments at the same time as those in the FAP intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Health Questionnaire-9 (PHQ-9)

    based directly on the nine diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Diploma in Social Medicine-IV

    Measured: Baseline

  2. Patient Health Questionnaire-9 (PHQ-9)

    based directly on the nine diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Diploma in Social Medicine-IV

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  3. Patient Health Questionnaire-9 (PHQ-9)

    based directly on the nine diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Diploma in Social Medicine-IV

    Measured: Follow Up (3 Months after Intervention)

Secondary outcomes (24)
  1. World Health Organization Quality of Life

    a measure of an individual's physical health, psychological state, personal beliefs, social relationships and their relationship to salient features of their environment.

    Measured: Baseline

  2. World Health Organization Quality of Life

    a measure of an individual's physical health, psychological state, personal beliefs, social relationships and their relationship to salient features of their environment.

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  3. World Health Organization Quality of Life

    a measure of an individual's physical health, psychological state, personal beliefs, social relationships and their relationship to salient features of their environment.

    Measured: Follow Up (3 Months after Intervention)

  4. Drug Abuse Screening Test

    a sensitive screening instrument for the abuse of drugs other than alcohol

    Measured: Baseline

  5. Drug Abuse Screening Test

    a sensitive screening instrument for the abuse of drugs other than alcohol

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  6. Drug Abuse Screening Test

    a sensitive screening instrument for the abuse of drugs other than alcohol

    Measured: Follow Up (3 Months after Intervention)

  7. Paffenbarger Physical Activity Questionnaire

    asks participants about their current and previous exercise habits

    Measured: Baseline

  8. Paffenbarger Physical Activity Questionnaire

    asks participants about their current and previous exercise habits

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  9. Paffenbarger Physical Activity Questionnaire

    asks participants about their current and previous exercise habits

    Measured: Follow Up (3 Months after Intervention)

  10. Proximal Change Variables

    assesses participant's eating habits as well as tobacco and alcohol use

    Measured: Baseline

  11. Proximal Change Variables

    assesses participant's eating habits as well as tobacco and alcohol use

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  12. Proximal Change Variables

    assesses participant's eating habits as well as tobacco and alcohol use

    Measured: Follow Up (3 Months after Intervention)

  13. Weight Control Questionnaire

    asks participants to report if they have ever used any weight control practices

    Measured: Baseline

  14. Weight Control Questionnaire

    asks participants to report if they have ever used any weight control practices

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  15. Weight Control Questionnaire

    asks participants to report if they have ever used any weight control practices

    Measured: Follow Up (3 Months after Intervention)

  16. Fear of Intimacy Scale (FIS)

    The FIS is a 35 item measure of self-disclosure, social intimacy, and social desirability. All items are scored on a 5-point Likert scale

    Measured: Baseline

  17. Fear of Intimacy Scale (FIS)

    The FIS is a 35 item measure of self-disclosure, social intimacy, and social desirability. All items are scored on a 5-point Likert scale

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  18. Fear of Intimacy Scale (FIS)

    The FIS is a 35 item measure of self-disclosure, social intimacy, and social desirability. All items are scored on a 5-point Likert scale

    Measured: Follow Up (3 Months after Intervention)

  19. Social Support Survey

    provides an assessment of several domains of social support including tangible support, emotional support, affective support, and positive support

    Measured: Baseline

  20. Social Support Survey

    provides an assessment of several domains of social support including tangible support, emotional support, affective support, and positive support

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  21. Social Support Survey

    provides an assessment of several domains of social support including tangible support, emotional support, affective support, and positive support

    Measured: Follow Up (3 Months after Intervention)

  22. University of California, Los Angeles Loneliness Scale

    designed to measure one's subjective feelings of loneliness as well as feelings of social isolation

    Measured: Baseline

  23. University of California, Los Angeles Loneliness Scale

    designed to measure one's subjective feelings of loneliness as well as feelings of social isolation

    Measured: Post Intervention (Approximately 12 Weeks from Baseline)

  24. University of California, Los Angeles Loneliness Scale

    designed to measure one's subjective feelings of loneliness as well as feelings of social isolation

    Measured: Follow Up (3 Months after Intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2018
  2. Study startJan 2019 (estimated)
  3. Primary completionJun 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03766360
Sponsor's protocol ID
STUDY00005196
Acronym
SIBS
Status last verified
Dec 2018
First submitted
27 Nov 2018
Last updated
6 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248-256.e5. doi: 10.1016/j.amjmed.2008.09.041.

    PubMed 19272486
  • Switzer, N.J., Debru, E., Church, N. et al. Curr Cardiovasc Risk Rep (2016) 10: 12. https://doi.org/10.1007/s12170-016-0492-7

  • Mitchell JE, Crosby R, de Zwaan M, Engel S, Roerig J, Steffen K, Gordon KH, Karr T, Lavender J, Wonderlich S. Possible risk factors for increased suicide following bariatric surgery. Obesity (Silver Spring). 2013 Apr;21(4):665-72. doi: 10.1002/oby.20066.

    PubMed 23404774
  • Sarwer DB, Moore RH, Spitzer JC, Wadden TA, Raper SE, Williams NN. A pilot study investigating the efficacy of postoperative dietary counseling to improve outcomes after bariatric surgery. Surg Obes Relat Dis. 2012 Sep-Oct;8(5):561-8. doi: 10.1016/j.soard.2012.02.010. Epub 2012 Mar 21.

    PubMed 22551576
  • Kohlenberg, R. J., & Tsai, M. (1991). Functional analytic psychotherapy: Creating intense and curative therapeutic relationships. New York, NY, US: Plenum Press. http://dx.doi.org/10.1007/978-0-387-70855-3

Questions about this trial

What is this clinical trial studying?

A study testing Functional Analytical Psychotherapy (FAP) in people with Depression and Quality of Life, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jonathan Kanter, PhD (206-685-7462, jonkan@uw.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Health Questionnaire-9 (PHQ-9) (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03766360, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2018; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in